- Researchers from Brigham conducted a meta-analysis of 15 randomized studies involving patients taking GLP-1 medications, which are commonly used for type 2 diabetes and weight loss. The findings suggest that these medications only slightly delay gastric emptying by about 36 minutes, indicating that they can be safely continued before surgeries with minor precautions.
- There is currently inconsistency in guidelines from the American Society of Anesthesiologists and the American Gastroenterological Association regarding the management of GLP-1 medication use before procedures. This inconsistency highlights the need for more unified recommendations.
- Based on the study’s findings, the researchers recommend updating the guidelines to suggest that patients can continue their GLP-1 therapy while adhering to a liquid-only diet the day prior to endoscopic procedures. This approach aims to minimize the risk of aspiration and improve patient safety during surgeries.
The study indicates that GLP-1 medications, with proper precautions, can be safely continued before surgical procedures. This calls for updated and consistent guidelines to ensure patient safety and effective perioperative management.